Title : Therapeutic intervention with complement and beta-glucan in cancer.

Pub. Date : 1999 May

PMID : 10408367






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This review discusses a novel type of immunotherapy for cancer that uses soluble yeast beta-glucan to override the normal resistance of iC3b-opsonized tumor cells to the cytotoxic activation of phagocyte and NK cell CR3, allowing this important effector mechanism of the C system to function against tumor cells in the same way that it normally functions against bacteria and yeast. beta-Glucans teratocarcinoma-derived growth factor 1 pseudogene 3 Homo sapiens